vs
Alkermes plc.（ALKS）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
Alkermes plc.的季度营收约是GIBRALTAR INDUSTRIES, INC.的1.7倍（$384.5M vs $225.0M），GIBRALTAR INDUSTRIES, INC.同比增速更快（24.9% vs -10.6%），Alkermes plc.自由现金流更多（$170.0M vs $26.2M），过去两年Alkermes plc.的营收复合增速更高（4.8% vs -12.3%）
Alkermes plc是一家全产业链布局的生物制药企业，专注于精神障碍与神经系统疾病相关药物的研发。公司1987年由迈克尔·沃尔创立，2011年9月与原Élan集团旗下的药物制剂及生产部门Elan Drug Technologies合并，总部位于都柏林，在马萨诸塞州沃尔瑟姆设有研发中心，俄亥俄州威尔明顿建有生产基地。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
ALKS vs ROCK — 直观对比
营收规模更大
ALKS
是对方的1.7倍
$225.0M
营收增速更快
ROCK
高出35.5%
-10.6%
自由现金流更多
ALKS
多$143.8M
$26.2M
两年增速更快
ALKS
近两年复合增速
-12.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $384.5M | $225.0M |
| 净利润 | $49.3M | — |
| 毛利率 | 88.0% | 25.3% |
| 营业利润率 | 15.1% | 7.9% |
| 净利率 | 12.8% | — |
| 营收同比 | -10.6% | 24.9% |
| 净利润同比 | -66.3% | — |
| 每股收益（稀释后） | $0.29 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALKSROCK
| Q4 25 | $384.5M | $225.0M | ||
| Q3 25 | $394.2M | $310.9M | ||
| Q2 25 | $390.7M | $309.5M | ||
| Q1 25 | $306.5M | $290.0M | ||
| Q4 24 | $430.0M | $180.1M | ||
| Q3 24 | $378.1M | $277.1M | ||
| Q2 24 | $399.1M | $273.6M | ||
| Q1 24 | $350.4M | $292.5M |
净利润ALKSROCK
| Q4 25 | $49.3M | — | ||
| Q3 25 | $82.8M | $-89.1M | ||
| Q2 25 | $87.1M | $26.0M | ||
| Q1 25 | $22.5M | $21.1M | ||
| Q4 24 | $146.5M | — | ||
| Q3 24 | $92.4M | $34.0M | ||
| Q2 24 | $91.4M | $32.2M | ||
| Q1 24 | $36.8M | $24.9M |
毛利率ALKSROCK
| Q4 25 | 88.0% | 25.3% | ||
| Q3 25 | 86.9% | 26.6% | ||
| Q2 25 | 87.3% | 28.4% | ||
| Q1 25 | 83.9% | 26.8% | ||
| Q4 24 | 85.6% | 29.0% | ||
| Q3 24 | 83.3% | 29.4% | ||
| Q2 24 | 84.6% | 30.5% | ||
| Q1 24 | 83.3% | 28.9% |
营业利润率ALKSROCK
| Q4 25 | 15.1% | 7.9% | ||
| Q3 25 | 22.6% | 12.8% | ||
| Q2 25 | 23.8% | 12.8% | ||
| Q1 25 | 4.5% | 8.8% | ||
| Q4 24 | 37.8% | 13.3% | ||
| Q3 24 | 27.7% | 15.6% | ||
| Q2 24 | 27.5% | 14.9% | ||
| Q1 24 | 12.4% | 10.8% |
净利率ALKSROCK
| Q4 25 | 12.8% | — | ||
| Q3 25 | 21.0% | -28.6% | ||
| Q2 25 | 22.3% | 8.4% | ||
| Q1 25 | 7.3% | 7.3% | ||
| Q4 24 | 34.1% | — | ||
| Q3 24 | 24.4% | 12.3% | ||
| Q2 24 | 22.9% | 11.8% | ||
| Q1 24 | 10.5% | 8.5% |
每股收益（稀释后）ALKSROCK
| Q4 25 | $0.29 | — | ||
| Q3 25 | $0.49 | $-2.98 | ||
| Q2 25 | $0.52 | $0.87 | ||
| Q1 25 | $0.13 | — | ||
| Q4 24 | $0.88 | — | ||
| Q3 24 | $0.55 | $1.11 | ||
| Q2 24 | $0.53 | $1.05 | ||
| Q1 24 | $0.21 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $388.6M | $115.7M |
| 总债务越低越好 | — | $0 |
| 股东权益账面价值 | $1.8B | $950.4M |
| 总资产 | $2.5B | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资ALKSROCK
| Q4 25 | $388.6M | $115.7M | ||
| Q3 25 | $616.4M | $89.4M | ||
| Q2 25 | $521.2M | $43.3M | ||
| Q1 25 | $399.8M | $25.1M | ||
| Q4 24 | $291.1M | $269.5M | ||
| Q3 24 | $396.3M | $228.9M | ||
| Q2 24 | $535.1M | $179.1M | ||
| Q1 24 | $420.8M | $146.7M |
总债务ALKSROCK
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益ALKSROCK
| Q4 25 | $1.8B | $950.4M | ||
| Q3 25 | $1.7B | $951.8M | ||
| Q2 25 | $1.6B | $1.0B | ||
| Q1 25 | $1.5B | $1.0B | ||
| Q4 24 | $1.5B | $1.0B | ||
| Q3 24 | $1.3B | $1.0B | ||
| Q2 24 | $1.3B | $975.7M | ||
| Q1 24 | $1.3B | $940.2M |
总资产ALKSROCK
| Q4 25 | $2.5B | $1.4B | ||
| Q3 25 | $2.3B | $1.4B | ||
| Q2 25 | $2.3B | $1.5B | ||
| Q1 25 | $2.1B | $1.4B | ||
| Q4 24 | $2.1B | $1.4B | ||
| Q3 24 | $2.2B | $1.4B | ||
| Q2 24 | $2.2B | $1.4B | ||
| Q1 24 | $2.1B | $1.3B |
负债/权益比ALKSROCK
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $170.1M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | $170.0M | $26.2M |
| 自由现金流率自由现金流/营收 | 44.2% | 11.7% |
| 资本支出强度资本支出/营收 | 0.0% | 4.1% |
| 现金转化率经营现金流/净利润 | 3.45× | — |
| 过去12个月自由现金流最近4个季度 | $480.3M | $120.6M |
8季度趋势，按日历期对齐
经营现金流ALKSROCK
| Q4 25 | $170.1M | $35.5M | ||
| Q3 25 | $101.7M | $73.0M | ||
| Q2 25 | $150.2M | $44.9M | ||
| Q1 25 | $98.8M | $13.7M | ||
| Q4 24 | $190.4M | $19.9M | ||
| Q3 24 | $81.6M | $64.7M | ||
| Q2 24 | $146.0M | $36.5M | ||
| Q1 24 | $21.1M | $53.2M |
自由现金流ALKSROCK
| Q4 25 | $170.0M | $26.2M | ||
| Q3 25 | $84.4M | $64.8M | ||
| Q2 25 | $137.2M | $27.3M | ||
| Q1 25 | $88.7M | $2.3M | ||
| Q4 24 | $180.6M | $14.1M | ||
| Q3 24 | $73.3M | $60.5M | ||
| Q2 24 | $138.9M | $33.5M | ||
| Q1 24 | $12.8M | $48.8M |
自由现金流率ALKSROCK
| Q4 25 | 44.2% | 11.7% | ||
| Q3 25 | 21.4% | 20.8% | ||
| Q2 25 | 35.1% | 8.8% | ||
| Q1 25 | 28.9% | 0.8% | ||
| Q4 24 | 42.0% | 7.8% | ||
| Q3 24 | 19.4% | 21.8% | ||
| Q2 24 | 34.8% | 12.2% | ||
| Q1 24 | 3.6% | 16.7% |
资本支出强度ALKSROCK
| Q4 25 | 0.0% | 4.1% | ||
| Q3 25 | 4.4% | 2.6% | ||
| Q2 25 | 3.3% | 5.7% | ||
| Q1 25 | 3.3% | 3.9% | ||
| Q4 24 | 2.3% | 3.3% | ||
| Q3 24 | 2.2% | 1.5% | ||
| Q2 24 | 1.8% | 1.1% | ||
| Q1 24 | 2.4% | 1.5% |
现金转化率ALKSROCK
| Q4 25 | 3.45× | — | ||
| Q3 25 | 1.23× | — | ||
| Q2 25 | 1.72× | 1.73× | ||
| Q1 25 | 4.40× | 0.65× | ||
| Q4 24 | 1.30× | — | ||
| Q3 24 | 0.88× | 1.90× | ||
| Q2 24 | 1.60× | 1.13× | ||
| Q1 24 | 0.57× | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALKS
| Vivitrol | $124.1M | 32% |
| Aristada And Aristada Initio | $97.2M | 25% |
| LYBALVI | $94.1M | 24% |
| Royalty | $65.7M | 17% |
| Manufacturing Revenue | $3.3M | 1% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
